VANGUARD GROUP INC, a registered investment adviser, initiated a new position in Hologic, Inc. (NASDAQ:HOLX) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 23,884,621 shares of the Healthcare company, valued at approximately $1.8B as of the filing date.
Hologic, Inc.'s stock currently trades at $74.99 with a market capitalization of $16.7B.
